H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: CHINARES PHARMA(03320) the Revenue is 156.81 B (+9.11%), Miss estimate;the EBIT is 8.084 B (+1.02%), Miss estimate;the EPS is 0.408 (+13.49%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
156.81B9.11%
160.51B11.68%
-3.70B2.57%
EBITMiss expectations
8.08B1.02%
9.67B20.87%
-1.59B19.85%
EPSMiss expectations
0.408213.49%
0.46328.73%
-0.054815.24%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf